A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma

• Main Authors: Shang L., Liu H.-J., Hao J.-J., Jiang Y.-Y., Shi F., Zhang Y., Cai Y., Xu X., Jia X.-M., Zhan Q.-M., Wang M.-R.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: 2019
• Subjects: epidermal growth factor receptor; phosphatidylinositol 3 kinase; phosphatidylinositol 3 kinase p110alpha; phosphatidylinositol 3 kinase p85alpha; protein p53; stem cell factor receptor; tissue inhibitor of metalloproteinase 1; unclassified drug; EGFR protein, human; phosphatidylinositol 4,5 bisphosphate 3 kinase; TIMP1 protein, human; TP53 protein, human; tumor marker; adult; aged; Article; cancer prognosis; controlled study; esophageal squamous cell carcinoma; female; human; human tissue; immunohistochemistry; major clinical study; male; overall survival; protein expression; Carcinoma, Squamous Cell; Esophageal Neoplasms; Kaplan Meier method; metabolism; middle aged; mortality; prognosis; proportional hazards model; Class Ia Phosphatidylinositol 3-Kinase; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-kit; Receptor, Epidermal Growth Factor; Tissue Inhibitor of Metalloproteinase-1; Tumor Markers, Biological; Tumor Suppressor Protein p53
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161765
• Institution: National University of Singapore

10.1371/journal.pone.0111045